Expression of Human Apolipoprotein E4 in Neurons Causes Hyperphosphorylation of Protein Tau in the Brains of Transgenic Mice

Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443

Strittmatter, 1994, Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease, Proc Natl Acad Sci USA, 91, 11183, 10.1073/pnas.91.23.11183

Olichney, 1996, The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant, Neurology, 47, 190, 10.1212/WNL.47.1.190

Nagy, 1995, Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease, Neuroscience, 69, 757, 10.1016/0306-4522(95)00331-C

Gearing, 1996, A beta-peptide length and apolipoprotein E genotype in Alzheimer's disease, Ann Neurol, 39, 395, 10.1002/ana.410390320

Ghebremedhin, 1998, High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes, Exp Neurol, 153, 152, 10.1006/exnr.1998.6860

Ahmed, 1999, The −491 A/T polymorphism of the apolipoprotein E gene is associated with the ApoEepsilon4 allele, and Alzheimer's disease, Neurosci Lett, 263, 217, 10.1016/S0304-3940(99)00126-3

Lambert, 1998, A new polymorphism in the ApoE promoter associated with risk of developing Alzheimer's disease, Hum Mol Genet, 7, 533, 10.1093/hmg/7.3.533

Bullido, 1998, A polymorphism in the regulatory region of ApoE associated with risk for Alzheimer's dementia, Nat Genet, 18, 69, 10.1038/ng0198-69

Artiga, 1998, Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene, FEBS Lett, 421, 105, 10.1016/S0014-5793(97)01543-3

Lambert, 1998, Pronounced impact of Th1/E47cs mutation compared with −491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease, Hum Mol Genet, 7, 1511, 10.1093/hmg/7.9.1511

Alberts, 1995, ApoE genotype, and survival from intracerebral haemorrhage, Lancet, 346, 575, 10.1016/S0140-6736(95)91411-0

Jordan, 1997, Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing, J Am Med Assoc, 278, 136, 10.1001/jama.1997.03550020068040

Mayeux, 1995, Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease, Neurology, 45, 555, 10.1212/WNL.45.3.555

Nicoll, 1995, Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid β-protein following head injury, Nat Med, 1, 135, 10.1038/nm0295-135

Reed, 1994, Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele, Arch Neurol, 51, 1189, 10.1001/archneur.1994.00540240033012

Tardiff, 1997, Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center, Ann Thorac Surg, 64, 715, 10.1016/S0003-4975(97)00757-1

Han, 1994, Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease, and in age-matched controls, Exp Neurol, 128, 13, 10.1006/exnr.1994.1108

Metzger, 1996, Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease, J Neuropathol Exp Neurol, 55, 372, 10.1097/00005072-199603000-00013

Xu, 1999, Specific regional transcription of apolipoprotein E in human brain neurons, Am J Pathol, 154, 601, 10.1016/S0002-9440(10)65305-9

Xu, 1998, Regionally specific neuronal expression of human APOE gene in transgenic mice, Neurosci Lett, 246, 65, 10.1016/S0304-3940(98)00247-X

Xu, 1996, Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice, Neurobiol Dis, 3, 229, 10.1006/nbdi.1996.0023

Roses, 1998, cis-acting human ApoE tissue expression element is associated with human pattern of intraneuronal ApoE in transgenic mice, Neurobiol Aging, 19, S53, 10.1016/S0197-4580(98)00030-X

Einstein, 1998, Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology, J Neuropathol Exp Neurol, 57, 1190, 10.1097/00005072-199812000-00011

Soulié Cathia, 1999, Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE, Neurosci Lett, 265, 147, 10.1016/S0304-3940(99)00167-6

Dupont-Wallois, 1997, ApoE synthesis in human neuroblastoma cells, Neurobiol Dis, 4, 356, 10.1006/nbdi.1997.0155

Horsburgh, 1996, Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat, Neuropathol Appl Neurobiol, 22, 342, 10.1111/j.1365-2990.1996.tb01113.x

Ali, 1996, Induction of apolipoprotein E mRNA in the hippocampus of the gerbil after transient global ischemia, Brain Res Mol Brain Res, 38, 37, 10.1016/0169-328X(95)00301-8

Ishimaru, 1996, Cystatin C, and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus, Brain Res, 709, 155, 10.1016/0006-8993(95)01232-X

Zarow, 1998, Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning, Exp Neurol, 149, 79, 10.1006/exnr.1997.6709

DeMattos, 1998, A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins, J Biol Chem, 273, 4206, 10.1074/jbc.273.7.4206

Holtzman, 1995, Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line, Proc Natl Acad Sci USA, 92, 9480, 10.1073/pnas.92.21.9480

Nathan, 1995, The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization, J Biol Chem, 270, 19791, 10.1074/jbc.270.34.19791

Nathan, 1994, Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro, Science, 264, 850, 10.1126/science.8171342

Bellosta, 1995, Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth, J Biol Chem, 270, 27063, 10.1074/jbc.270.45.27063

Puttfarcken, 1997, Effect of apolipoprotein E on neurite outgrowth and β-amyloid-induced toxicity in developing rat primary hippocampal cultures, J Neurochem, 68, 760, 10.1046/j.1471-4159.1997.68020760.x

Fagan, 1996, Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth, and is a ligand for the low density lipoprotein receptor-related protein, J Biol Chem, 271, 30121, 10.1074/jbc.271.47.30121

Huang, 1994, Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease, Neurosci Lett, 182, 55, 10.1016/0304-3940(94)90204-6

Moechars, 1996, Expression in brain of amyloid precursor protein mutated in the α-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice, EMBO J, 15, 1265, 10.1002/j.1460-2075.1996.tb00468.x

Brenner, 1994, GFAP promoter directs astrocyte-specific expression in transgenic mice, J Neurosci, 14, 1030, 10.1523/JNEUROSCI.14-03-01030.1994

Games, 1995, Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein, Nature, 373, 523, 10.1038/373523a0

te Riele, 1992, Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs, Proc Natl Acad Sci USA, 89, 5128, 10.1073/pnas.89.11.5128

Sasahara, 1991, PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model, Cell, 64, 217, 10.1016/0092-8674(91)90223-L

Johnson, 1995, Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes, Glia, 13, 174, 10.1002/glia.440130304

Umans, 1995, Targeted inactivation of the mouse α 2-macroglobulin gene, J Biol Chem, 270, 19778, 10.1074/jbc.270.34.19778

Evans, 1984, Expression of the Thy-1 glycoprotein gene by DNA-mediated gene transfer, Proc Natl Acad Sci USA, 81, 5532, 10.1073/pnas.81.17.5532

Ingraham, 1986, The mouse Thy-1.2 glyco-protein gene: complete sequence and identification of an unusual promoter, J Immunol, 136, 1482, 10.4049/jimmunol.136.4.1482

Morris, 1992, Thy-1, the enigmatic extrovert on the neuronal surface, BioEssays, 14, 715, 10.1002/bies.950141014

Kelley, 1994, Expression of Thy-1/lacZ fusion genes in the CNS of transgenic mice, Brain Res Mol Brain Res, 24, 261, 10.1016/0169-328X(94)90139-2

Gordon, 1987, Regulation of Thy-1 gene expression in transgenic mice, Cell, 50, 445, 10.1016/0092-8674(87)90498-3

Martinou, 1994, Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia, Neuron, 13, 1017, 10.1016/0896-6273(94)90266-6

Latham, 1995, Expression of X-linked genes in androgenetic, gynogenetic, and normal mouse preimplantation embryos, Dev Genet, 17, 212, 10.1002/dvg.1020170306

Bahr, 1998, Age-related phosphorylation and fragmentation events influence the distribution profiles of distinct tau isoforms in mouse brain, J Neuropathol Exp Neurol, 57, 111, 10.1097/00005072-199802000-00002

Tashiro, 1997, Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex, Neuroreport, 8, 2797, 10.1097/00001756-199708180-00029

Raber, 1998, Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females, Proc Natl Acad Sci USA, 95, 10914, 10.1073/pnas.95.18.10914

Genis, 1995, Phosphorylation of tau in apolipoprotein E-deficient mice, Neurosci Lett, 199, 5, 10.1016/0304-3940(95)12007-Q

Genis, 1999, Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment, J Neurochem, 72, 206, 10.1046/j.1471-4159.1999.0720206.x

Mercken, 1995, Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E, Neuroreport, 6, 2381, 10.1097/00001756-199511270-00025

Sun, 1998, Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins, J Neurosci, 18, 3261, 10.1523/JNEUROSCI.18-09-03261.1998

Bancher, 1989, Tau and ubiquitin immunoreactivity at different stages of formation of Alzheimer neurofibrillary tangles, Prog Clin Biol Res, 317, 837

Brownlees, 1997, Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenes, Neuroreport, 8, 3251, 10.1097/00001756-199710200-00013

James, 1996, Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase Mos, Neurobiol Aging, 17, 235, 10.1016/0197-4580(95)02068-3

Kayyali, 1997, Cytoskeletal changes in the brains of mice lacking calcineurin A α, J Neurochem, 68, 1668, 10.1046/j.1471-4159.1997.68041668.x

Brion, 1999, Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease, Am J Pathol, 154, 255, 10.1016/S0002-9440(10)65272-8

Gotz, 1995, Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform, EMBO J, 14, 1304, 10.1002/j.1460-2075.1995.tb07116.x

Spittaels, 1999, Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein, Am J Pathol, 155, 2153, 10.1016/S0002-9440(10)65533-2

Braak, 1995, Staging of Alzheimer's disease-related neurofibrillary changes, Neurobiol Aging, 16, 271, 10.1016/0197-4580(95)00021-6

Braak, 1996, Evolution of the neuropathology of Alzheimer's disease, Acta Neurol Scand Suppl, 165, 3, 10.1111/j.1600-0404.1996.tb05866.x

Ridet, 1997, Reactive astrocytes: cellular and molecular cues to biological function, Trends Neurosci, 20, 570, 10.1016/S0166-2236(97)01139-9

Rebeck, 1993, Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions, Neuron, 11, 575, 10.1016/0896-6273(93)90070-8

Strittmatter, 1993, Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc Natl Acad Sci USA, 90, 1977, 10.1073/pnas.90.5.1977

Wisniewski, 1992, Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid, Neurosci Lett, 135, 235, 10.1016/0304-3940(92)90444-C

Strittmatter, 1994, Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype, Exp Neurol, 125, 163, 10.1006/exnr.1994.1019

DeMattos, 1999, A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic, J Neurosci, 19, 2464, 10.1523/JNEUROSCI.19-07-02464.1999

Chartier-Harlin, 1994, Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region, Hum Mol Genet, 3, 569, 10.1093/hmg/3.4.569

Lambert, 1997, Distortion of allelic expression of apolipoprotein E in Alzheimer's disease, Hum Mol Genet, 6, 2151, 10.1093/hmg/6.12.2151

Poduslo, 1995, A closely linked gene to apolipoprotein E may serve as an additional risk factor for Alzheimer's disease, Neurosci Lett, 201, 81, 10.1016/0304-3940(95)12158-Z

Laws, 1999, The −491 AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease, Neuroreport, 10, 879, 10.1097/00001756-199903170-00038

Mui, 1996, A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele, Neurology, 47, 196, 10.1212/WNL.47.1.196

Marques, 1996, A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity, Neuroreport, 7, 2529, 10.1097/00001756-199611040-00025

Tolar, 1997, Neurotoxicity of the 22 kd thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated, J Neurosci, 17, 5678, 10.1523/JNEUROSCI.17-15-05678.1997

Crutcher, 1994, Neurite degeneration elicited by apolipoprotein E peptides, Exp Neurol, 130, 120, 10.1006/exnr.1994.1191